Table 5.
Nursing process and outcomes were compared.
| Variables | Total (n = 1,575) | Trajectory 1 (n = 246) | Trajectory 2 (n = 464) | Trajectory 3 (n = 225) | Trajectory 4 (n = 435) | Trajectory 5 (n = 205) | p |
|---|---|---|---|---|---|---|---|
| Los ICU, M (Q₁, Q₃) | 12.52 (8.64, 20.10) | 12.18 (8.04, 19.89) | 11.61 (8.29, 18.69) | 12.62 (9.26, 20.99) | 13.67 (9.13, 0.81) | 12.56 (8.10, 21.32) | 0.025 |
| Hosp Outcome 28d, n(%) | <0.001 | ||||||
| No | 1,071 (68.00) | 189 (76.83) | 315 (67.89) | 167 (74.22) | 291 (66.90) | 109 (53.17) | |
| Yes | 504 (32.00) | 57 (23.17) | 149 (32.11) | 58 (25.78) | 144 (33.10) | 96 (46.83) | |
| Propofol ICU Used, n(%) | 0.603 | ||||||
| No | 189 (12.00) | 30 (12.20) | 61 (13.15) | 20 (8.89) | 54 (12.41) | 24 (11.71) | |
| Yes | 1,386 (88.00) | 216 (87.80) | 403 (86.85) | 205 (91.11) | 381 (87.59) | 181 (88.29) | |
| Dexmedetomidine ICU Used, n(%) | 0.018 | ||||||
| No | 732 (46.48) | 102 (41.46) | 198 (42.67) | 107 (47.56) | 213 (48.97) | 112 (54.63) | |
| Yes | 843 (53.52) | 144 (58.54) | 266 (57.33) | 118 (52.44) | 222 (51.03) | 93 (45.37) | |
| Midazolam ICU Used, n(%) | 0.693 | ||||||
| No | 1,185 (75.24) | 187 (76.02) | 342 (73.71) | 177 (78.67) | 324 (74.48) | 155 (75.61) | |
| Yes | 390 (24.76) | 59 (23.98) | 122 (26.29) | 48 (21.33) | 111 (25.52) | 50 (24.39) | |
| Tramadol ICU Used, n(%) | 0.476 | ||||||
| No | 1,463 (92.89) | 232 (94.31) | 429 (92.46) | 204 (90.67) | 404 (92.87) | 194 (94.63) | |
| Yes | 112 (7.11) | 14 (5.69) | 35 (7.54) | 21 (9.33) | 31 (7.13) | 11 (5.37) | |
| Vasoactive, n(%) | 0.237 | ||||||
| No | 260 (16.51) | 52 (21.14) | 71 (15.30) | 31 (13.78) | 72 (16.55) | 34 (16.59) | |
| Yes | 1,315 (83.49) | 194 (78.86) | 393 (84.70) | 194 (86.22) | 363 (83.45) | 171 (83.41) | |
| Liquid Input day 1, M (Q₁, Q₃) | 19861.00 (11857.50, 29528.50) | 13064.00 (7595.00, 19181.50) | 17630.00 (10747.50, 23925.00) | 28700.00 (19620.00, 37806.00) | 20990.00 (12828.50, 31271.00) | 25854.00 (15470.00, 35193.00) | <0.001 |
| Liquid Input day 2, M (Q₁, Q₃) | 14300.00 (9055.00, 21977.00) | 9740.00 (6815.50, 14237.50) | 13205.00 (8351.25, 19305.00) | 15930.00 (10925.00, 23730.00) | 15655.00 (10280.00, 23862.50) | 19736.00 (13570.00, 27988.00) | <0.001 |
| Liquid Input day 3, M (Q₁, Q₃) | 12750.00 (8292.50, 19730.00) | 9899.00 (6750.00, 13472.50) | 11625.00 (7997.50, 17551.25) | 13420.00 (8820.00, 20000.00) | 13368.00 (9285.00, 20755.00) | 18496.00 (12800.00, 27285.00) | <0.001 |
| Liquid Input day 4, M (Q₁, Q₃) | 11890.00 (7300.00, 18791.50) | 10250.00 (5992.40, 14600.00) | 10795.00 (7117.50, 17344.00) | 10970.00 (7320.00, 18100.00) | 12404.00 (7570.00, 19530.00) | 17900.00 (10360.00, 24600.00) | <0.001 |
| Liquid Input day 5, M (Q₁, Q₃) | 0970.00 (6385.00, 18690.00) | 9205.00 (5800.00, 15412.50) | 9872.50 (5859.75, 15901.50) | 10680.00 (6240.00, 18320.00) | 10970.00 (6600.00, 18910.00) | 17422.00 (10470.00, 23577.00) | <0.001 |